Piper Sandler raised the firm’s price target on HashiCorp to $25 from $22 and keeps a Neutral rating on the shares. The firm says Q4 was generally an improvement compared to last quarter, with better trends within term-license, cloud, cRPO, and new business that showed high-quality net-adds. HashiCorp should be able to re-accelerate at some point if the monetization and go-to-market changes prove fruitful, but debate will remain on this for an extended period of time, Piper adds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HCP:
- HashiCorp Announces Fourth Quarter and Fiscal Year 2024 Financial Results
- HCP Upcoming Earnings Report: What to Expect?
- Moderna downgraded, Gap upgraded: Wall Street’s top analyst calls
- HashiCorp upgraded to Overweight from Equal Weight at Morgan Stanley
- HashiCorp to announce fourth quarter and fiscal year 2024 financial results Mar. 5, 2024